Stock·NASDAQ·Technology
MaxLinear, Inc. (MXL)
- Market cap
- $7.09B
- Dividend yield
- 0.00%
- Street target
- $100.00median of 11 analysts
- 52-week range
- $12.77 $128.30
The short version
Where MXL stands today, in four lines, and what CleaRank Financial AI makes of it.
MXL at a glance
MaxLinear, Inc. (MXL): Sell, 25/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($77.71 and $57.06).
- Earnings MXL beat estimates in 3 of its last 7 quarters, yet fell the next day after every one of them.
- Insiders Insiders sold $62.4M and made no open-market purchases over the last 18 months.
Figures as of October 16, 2026.
CleaRank Financial AI
MaxLinear, Inc. (MXL) is currently trading at $78.18, below its 20-day EMA but above its 50-day and 200-day moving averages ($77.71 and $57.06), indicating a mixed technical picture.
The company's recent earnings report on July 23, 2026, resulted in a substantial 21.54% price drop despite a slight EPS beat, highlighting investor concerns that outweigh positive revenue growth figures. This price action, coupled with heavy insider selling totaling $62.4 million, contributes to a bearish sentiment. Fundamentally, MaxLinear exhibits strong revenue growth of 55.2%, significantly outpacing the sector median of 24.2%. However, this is contrasted by negative profit margins (-18.24%) and a negative return on equity (-21.32%), suggesting profitability challenges. The company's price-to-sales ratio of 14.13 is also considerably higher than the sector median of 7.6, indicating a premium valuation that may be difficult to sustain given the current profitability issues.
Only on CleaRank
Figures we compute ourselves from MXL's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $78.18 is 0.6% above the 50-day simple moving average of $77.71.Price above its 200-day average ›
The price is 37.0% above the 200-day simple moving average of $57.06.50-day average above the 200-day ›
The 50-day average ($77.71) is 36.2% above the 200-day average ($57.06), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 57% of its 52-week range, between $12.77 and $128.30.
MXL share price
Pick a period: each tab shows how far MXL has moved over it, to the last close.
Today's trading
Where MXL sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
0/3P/S below the sector median ›
The price-to-sales ratio of 14.13 is 85.9% above the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $-103.8M on revenue of $568.9M, a net margin of -18.2%.Beat estimates in most recent reports ›
MXL beat the EPS estimate in 3 of its last 7 reports.
Key statistics
The headline figures for MXL.
As of October 16, 2026, MXL trades at $78.18, with a market value of $7.09B and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of MXL's valuation, growth and risks.
MaxLinear's valuation appears stretched given its current profitability, with a price-to-sales ratio of 14.13 significantly higher than the sector median of 7.6.
While the company is growing revenue at an impressive 55.2%, it is simultaneously reporting a negative profit margin of -18.24% and a negative return on equity of -21.32%. This indicates that despite top-line growth, the company is not yet translating sales into profits effectively. The debt-to-equity ratio stands at 0.31, which is below the sector median, suggesting a relatively healthy balance sheet in terms of leverage. However, the negative profit margins and return on equity raise concerns about the sustainability of its current market capitalization without a clear path to profitability. The company's forward revenue growth estimates are strong, with next year projected at 30.00%, but the negative EPS trend and current losses present a significant risk.
MXL against the Technology sector
How MXL compares with the median Technology stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, MXL trades at 14.13x, +86% versus the sector average of 7.60x.
Return vs XLK: Since May 5, 2025, MXL has gained 635.5% against a gain of 75.6% for XLK.
Performance against XLK
MXL and the Technology sector fund over the same days.
Revenue and earnings
How much MXL sells, and how much of it becomes profit.
Revenue growth: Revenue grew 29.7% in FY2025 to $468M, from $361M a year earlier.
Profit margin: The net margin was -29.2% in FY2025, up from -68.0% the year before.
Profitable: MXL lost $137M in FY2025.
Earnings reality check
Did MXL beat what analysts expected, and how did the stock react?
Earnings record: MXL beat the analyst estimate in 3 of the last 7 quarters.
Market reaction: The stock fell in the first session after 3 of those 3 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 23, 2026after close | $0.33 | $0.35 | +6.06% | -21.54% | -26.65% |
| Oct 23, 2025after close | $0.12 | $0.14 | +16.67% | -10.84% | -12.96% |
| Jul 23, 2025after close | $0.02 | $0.02 | +0.00% | +12.60% | +10.90% |
| Apr 23, 2025after close | -$0.05 | -$0.05 | +0.00% | -12.35% | -9.26% |
| Jan 29, 2025after close | -$0.13 | -$0.09 | +30.77% | -19.83% | -13.54% |
| Oct 23, 2024after close | -$0.32 | -$0.36 | -12.50% | +1.48% | -1.55% |
| Jul 24, 2024after close | -$0.19 | -$0.25 | -31.58% | +6.22% | +0.63% |
As of October 16, 2026, MXL has beaten the analyst EPS estimate in 3 of its last 7 reported quarters and fell in the first trading session after 3 of those beats; its latest report, on July 23, 2026, came in 6.06% above the estimate and the stock moved -21.54% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 42.8, in neutral territory.RSI above 50 ›
An RSI of 42.8 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of MXL
The score, the reasoning behind it, and what could move the price next.
Volume has surged 50.1% above its average, accompanying recent price action, suggesting increased market interest or volatility.
MaxLinear's price is currently trading below its 20-day EMA of $88.28, indicating short-term weakness, but remains above its 50-day SMA of $77.71 and 200-day SMA of $57.06, suggesting that longer-term support levels are holding. The 14-day RSI is at 42.84, signaling neutral momentum, neither overbought nor oversold. The stock's position below the 20-day EMA suggests potential for further downside in the near term, with the 50-day SMA acting as immediate support. The neutral RSI indicates a lack of strong directional conviction from a momentum perspective, but the significant volume accompanying recent price moves warrants close observation for potential trend shifts.
Strong Revenue Growth Exceeding Sector Averages ›
MaxLinear reported 55.2% revenue growth, significantly higher than the sector median of 24.2%, indicating strong demand for its products.
Source: Company FinancialsAnalyst Median Price Target of $100 ›
The median analyst price target for MaxLinear is $100, suggesting a potential upside of 27.9% from the current price, though this is tempered by current market conditions.
Source: Wall Street Analysts
Sharp Price Decline Post-Earnings ›
The stock experienced a 21.54% drop following the July 23, 2026, earnings report, highlighting negative market sentiment despite a slight EPS beat.
Source: Earnings Report Analysis
- MaxLinear's heavy insider selling, with over $62.4 million in dispositions, warrants extreme caution and suggests management may be anticipating further price declines or seeking liquidity.
- The stock's current position below its 20-day EMA, combined with neutral RSI momentum, indicates potential for near-term weakness, with the 50-day SMA at $77.71 serving as a key support level to watch.
Technical indicators
Momentum and trend for MXL, from its daily closes.
As of October 16, 2026, with MXL at $78.18, its 14-day RSI is 42.8 (neutral territory), its 50-day simple moving average is $77.71 and its 200-day is $57.06.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What MXL moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, MXL's 1-year correlation of daily returns is +0.47 with S&P 500 (SPY), +0.56 with Nasdaq 100 (QQQ), +0.16 with Bitcoin (BTC) and +0.10 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
7 of 11 analysts rate it a buy or strong buy, 4 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $100.00 is 27.9% above the price.More buy ratings than three months ago ›
7 of 11 rate it a buy now, against 7 of 11 three months ago.
MXL Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jul 24, 2026 | Roth Capital | Maintains | Buy |
| Jul 24, 2026 | Wells Fargo | Maintains | Equal-Weight |
| Jul 24, 2026 | Stifel | Maintains | Buy |
| Jul 24, 2026 | Susquehanna | Maintains | Neutral |
| Jul 24, 2026 | Needham | Maintains | Buy |
| Jul 20, 2026 | Wells Fargo | Maintains | Equal-Weight |
As of October 16, 2026, 11 Wall Street analysts cover MXL: 7 rate it a buy or strong buy, 4 a hold and 0 a sell or strong sell. Their 12-month price targets range from $40.00 to $125.00, with a median of $100.00, 27.9% above the price of $78.18.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
MXL trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
MXL moves about 6.6% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much MXL tends to move, against the market and on its own.
The long record
MXL's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
1/4Average daily move under 2% ›
The price has moved 6.58% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 87.8%, from December 2021 to April 2025, regained by May 2026.Most 1-year holds ended higher ›
46% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $40,320, against $42,525 in the S&P 500 (SPY).
MXL Drawdowns & Recovery
As of October 16, 2026, MXL's worst peak-to-trough fall over the last 10 years with dividends reinvested was -87.8% (December 2021 to April 2025); it regained that peak by May 2026, 13 months after the low, and 46% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into MXL in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: MXL trailed the S&P 500 over this period: $40,320 against $42,525.
A $10,000 investment in MXL in October 2016 would be worth about $40,320 today with dividends reinvested, compared with about $42,525 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to MXL, and which have not.
Strongest month, April: an average of +30.95%, up in 6 of 10 years.
Weakest month, March: an average of -5.93%, up in 3 of 10 years.
This month, October: has averaged -5.88%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, MXL's strongest calendar month has been April (average +30.95%, up in 6 of 10 years) and its weakest March (average -5.93%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in MXL, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in MXL today could grow to about $24,164 by 2036 in the base case, with a 90th-percentile outcome near $183,321 and a 10th-percentile outcome around $3,185. Projections are statistical simulations, not guarantees.
MXL Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $111 for MXL by 2030 in the base case, from $78.18 today (1.4x over 4 years). The 10th-percentile path ends near $30.89. These are outcomes of a Monte Carlo simulation run on MXL's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $44.99 | $85.39 | $162 | |
| 2028 | $37.68 | $93.27 | $231 | |
| 2029 | $33.58 | $102 | $309 | |
| 2030 | $30.89 | $111 | $401 | |
| 2031 | $29.00 | $122 | $509 |
Method: a lognormal simulation of MXL's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. MXL is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation.
Insider trading
What the people running the company have bought and sold.
MXL insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought MXL shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 16, 2026, MXL insiders reported 13 open-market sales worth $62.4M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 31, 2026 | Connie H. Kwong
Officer
|
Grant | 1.1K | - |
| Aug 17, 2026 | Kishore V Seendripu
Chief Executive Officer
|
Sell | 591.5K | $50.4M |
| May 26, 2026 | Thomas E Pardun
Director
|
Sell | 11.0K | $1.2M |
| May 22, 2026 | Connie H. Kwong
Officer
|
Grant | 3.7K | - |
| May 20, 2026 | Albert J Moyer
Director
|
Grant | 40.3K | - |
| May 20, 2026 | Kishore V Seendripu
Chief Executive Officer
|
Grant | 33.7K | - |
| May 8, 2026 | Connie H. Kwong
Officer
|
Sell | 35.0K | $3.4M |
| May 5, 2026 | Theodore L Tewksbury III
Director
|
Sell | 10.7K | $838.7K |
| May 4, 2026 | Albert J Moyer
Director
|
Sell | 15.7K | $1.2M |
| May 4, 2026 | Daniel A Artusi
Director
|
Sell | 10.5K | $825.7K |
| May 4, 2026 | Carolyn D Beaver
Director
|
Sell | 6.0K | $461.7K |
| May 1, 2026 | Daniel A Artusi
Director
|
Grant | 15.7K | - |
| May 1, 2026 | Carolyn D Beaver
Director
|
Grant | 15.7K | - |
| May 1, 2026 | Albert J Moyer
Director
|
Grant | 15.7K | - |
| May 1, 2026 | Kris Sennesael
Director
|
Grant | 2.1K | - |
| May 1, 2026 | Theodore L Tewksbury III
Director
|
Grant | 15.7K | - |
| Apr 29, 2026 | Connie H. Kwong
Officer
|
Sell | 4.1K | $238.8K |
| Apr 27, 2026 | Connie H. Kwong
Officer
|
Sell | 15.1K | $771.9K |
| Mar 6, 2026 | Steven G Litchfield
Chief Financial Officer
|
Sell | 44.9K | $746.4K |
| Mar 2, 2026 | Connie H. Kwong
Officer
|
Grant | 6.2K | - |
| Mar 2, 2026 | Kishore V Seendripu
Chief Executive Officer
|
Grant | 90.4K | - |
| Feb 20, 2026 | Connie H. Kwong
Officer
|
Grant | 10.9K | - |
| Feb 20, 2026 | Steven G Litchfield
Chief Financial Officer
|
Grant | 29.3K | - |
| Feb 20, 2026 | Steven G Litchfield
Chief Financial Officer
|
Grant | 45.4K | - |
| Feb 20, 2026 | Kishore V Seendripu
Chief Executive Officer
|
Grant | 105.9K | - |
| Oct 30, 2025 | Daniel A Artusi
Director
|
Sell | 29.8K | $463.1K |
| Aug 29, 2025 | Connie H. Kwong
Officer
|
Grant | 757 | - |
| Aug 26, 2025 | Steven G Litchfield
Chief Financial Officer
|
Sell | 102.2K | $1.8M |
| May 23, 2025 | Connie H. Kwong
Officer
|
Grant | 649 | - |
| May 20, 2025 | Steven G Litchfield
Chief Financial Officer
|
Grant | 1.2K | - |
| May 20, 2025 | Kishore V Seendripu
Chief Executive Officer
|
Grant | 4.0K | - |
| May 2, 2025 | Theodore L Tewksbury III
Director
|
Sell | 6.1K | $63.2K |
| May 1, 2025 | Daniel A Artusi
Director
|
Grant | 12.1K | - |
| May 1, 2025 | Carolyn D Beaver
Director
|
Grant | 12.1K | - |
| May 1, 2025 | Gregory P Dougherty
Director
|
Grant | 12.1K | - |
| May 1, 2025 | Tsu-Jae King Liu
Director
|
Grant | 12.1K | - |
| May 1, 2025 | Albert J Moyer
Director
|
Grant | 12.1K | - |
| May 1, 2025 | Thomas E Pardun
Director
|
Grant | 12.1K | - |
| May 1, 2025 | Theodore L Tewksbury III
Director
|
Grant | 12.1K | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.